VIA CANCELLOUS+ Trademark

Trademark Overview

On Monday, October 11, 2021, a trademark application was filed for VIA CANCELLOUS+ with the United States Patent and Trademark Office. The USPTO has given the VIA CANCELLOUS+ trademark a serial number of 97068680. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, September 30, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIA CANCELLOUS+ trademark is filed in the Pharmaceutical Products category with the following description:

Biological bone tissue intended for subsequent implantation
via cancellous+

General Information

Serial Number97068680
Word MarkVIA CANCELLOUS+
Filing DateMonday, October 11, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 1, 2022

Trademark Statements

Goods and ServicesBiological bone tissue intended for subsequent implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Thursday, October 14, 2021NEW APPLICATION ENTERED
Tuesday, November 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022PUBLISHED FOR OPPOSITION
Thursday, December 30, 2021ASSIGNED TO EXAMINER
Thursday, December 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 26, 2022SOU TEAS EXTENSION RECEIVED
Monday, September 26, 2022SOU EXTENSION 1 FILED
Monday, September 26, 2022SOU EXTENSION 1 GRANTED
Wednesday, September 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 2 FILED
Friday, March 3, 2023SOU EXTENSION 2 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU EXTENSION 3 FILED
Thursday, September 7, 2023SOU EXTENSION 3 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024PETITION TO REVIVE-GRANTED
Thursday, April 4, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, April 4, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, April 4, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, May 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 30, 2024SOU EXTENSION 4 GRANTED
Monday, September 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024SOU EXTENSION 5 FILED
Monday, September 30, 2024SOU EXTENSION 5 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cancellous subsequent implantation intended tissue bone biological